HCA Healthcare, Inc. $HCA Shares Sold by Burney Co.

Burney Co. cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,542 shares of the company’s stock after selling 3,907 shares during the quarter. Burney Co.’s holdings in HCA Healthcare were worth $12,165,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare in the second quarter valued at approximately $27,000. Clearstead Trust LLC boosted its holdings in shares of HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the last quarter. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the second quarter valued at $27,000. Saudi Central Bank acquired a new stake in HCA Healthcare during the 1st quarter worth about $26,000. Finally, Harbor Capital Advisors Inc. lifted its holdings in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 0.7%

NYSE:HCA opened at $477.30 on Friday. The firm has a market cap of $108.92 billion, a P/E ratio of 18.45, a price-to-earnings-growth ratio of 1.40 and a beta of 1.36. The stock has a 50 day moving average of $475.66 and a two-hundred day moving average of $420.04. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the previous year, the business earned $4.90 earnings per share. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Robert W. Baird boosted their price target on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Royal Bank Of Canada increased their price target on shares of HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a report on Friday, December 19th. Stephens upped their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Cowen restated a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a report on Thursday, November 13th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $479.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.